Clinical Trials Browser

Terminated × OTHER × Carcinoma, Lobular × Clear all

NCT06408168 2026-01-05

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

Phase 2 Terminated

Carcinoma, Lobular

NCT04252859 2025-05-18

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

Phase 2 Terminated

44 enrolled 15 charts

Carcinoma, Lobular

NCT02137252 2021-11-16

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Phase 2 Terminated

3 enrolled 4 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular